Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001982082 | SCV002210257 | uncertain significance | Renal carnitine transport defect | 2021-08-27 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine with glutamic acid at codon 18 of the SLC22A5 protein (p.Gln18Glu). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and glutamic acid. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004699569 | SCV005202400 | uncertain significance | not specified | 2024-07-27 | criteria provided, single submitter | clinical testing |